https://european-biotechnology.net/wp-content/uploads/2025/12/San-Antonio-Breast-Cancer-Symposium-1030x513-1.jpg5131030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-12 06:09:302025-12-12 06:09:30Pfizer presents data for Tukysa in HER2-positive breast cancer
https://european-biotechnology.net/wp-content/uploads/2025/12/Giredestrant-structure_Pubchem-e1765533664263.png232300Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-12 05:01:162025-12-12 05:01:16Roche presents details on breast cancer pill giredestrant
https://european-biotechnology.net/wp-content/uploads/2025/12/Product_Award_winners-1030x775-1.png7751030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-09 08:51:222025-12-09 08:51:22SLAS announces finalists for the 2026 Ignite Award
https://european-biotechnology.net/wp-content/uploads/2025/12/MMs-team-e1765185593845-1030x580-1.jpg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-08 09:20:002025-12-08 09:20:00Melt&Marble secures €7.3m Series A to scale designer fats
https://european-biotechnology.net/wp-content/uploads/2025/12/RS5629_AdobeStock_127114772-scr.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-08 08:53:532025-12-08 08:53:53Poolbeg takes centre stage in CRS research
https://european-biotechnology.net/wp-content/uploads/2025/12/Orano-Meds-production-facility-e1764923942582-1030x580-1.jpg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-05 08:39:082025-12-05 08:39:08Orano Med and Roche ink clincical distribution deal in radiopharmacy
